C-ERBB-2 ONCOPROTEIN EXPRESSION IN MAMMARY AND EXTRAMAMMARY PAGETS-DISEASE - AN IMMUNOHISTOCHEMICAL STUDY

被引:72
作者
KEATINGS, L
SINCLAIR, J
WRIGHT, C
CORBETT, IP
WATCHORN, C
HENNESSY, C
ANGUS, B
LENNARD, T
HORNE, CHW
机构
[1] UNIV NEWCASTLE UPON TYNE,DEPT PATHOL,NEWCASTLE TYNE NE1 7RU,TYNE & WEAR,ENGLAND
[2] UNIV NEWCASTLE UPON TYNE,DEPT SURG,NEWCASTLE TYNE NE1 7RU,TYNE & WEAR,ENGLAND
关键词
breast; carcinoma; c‐erbB‐2; oncogene; Paget's disease;
D O I
10.1111/j.1365-2559.1990.tb00714.x
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Over‐expression of the c‐erbB‐2 oncogene occurs in a proportion of human adenocarcinomas and in breast carcinoma is associated with poorer prognosis. Sections of formalin‐fixed, paraffin‐embedded tumour tissue from 22 patients with mammary and extramammary Paget's disease have been stained immunohistochemically using a monoclonal antibody (NCL‐CB11) raised against a synthetic peptide from the C‐terminal end of the predicted equence of the c‐erbB‐2 protein product. All 12 cases of mammary Paget's disease showed membrane staining of intra‐epidermal cells, indicating c‐erbB‐2 over‐expression. Sections of underlying ductal breast carcinoma were available in nine cases; all nine tumours were c‐erbB‐2 positive and in eight the in situ component was of comedo or solid type. There was membrane staining of tumour cells in four of the 10 cases of extramammary Paget's disease; staining intensity was generally weaker than that observed in the cases of mammary disease. The possible implications of these findings for the histogenesis of both mammary and extramammary Paget's disease are discussed. Copyright © 1990, Wiley Blackwell. All rights reserved
引用
收藏
页码:243 / 247
页数:5
相关论文
共 35 条
  • [1] NCL-5D3 - A NEW MONOCLONAL-ANTIBODY RECOGNIZING LOW-MOLECULAR WEIGHT CYTOKERATINS EFFECTIVE FOR IMMUNOHISTOCHEMISTRY USING FIXED PARAFFIN-EMBEDDED TISSUE
    ANGUS, B
    PURVIS, J
    STOCK, D
    WESTLEY, BR
    SAMSON, ACR
    ROUTLEDGE, EG
    CARPENTER, FH
    HORNE, CHW
    [J]. JOURNAL OF PATHOLOGY, 1987, 153 (04) : 377 - 384
  • [2] AN IMMUNOHISTOCHEMICAL EVALUATION OF C-ERB-2 EXPRESSION IN HUMAN-BREAST CARCINOMA
    BARNES, DM
    LAMMIE, GA
    MILLIS, RR
    GULLICK, WL
    ALLEN, DS
    ALTMAN, DG
    [J]. BRITISH JOURNAL OF CANCER, 1988, 58 (04) : 448 - 452
  • [3] BREAST-CANCER AND A PROTO-ONCOGENE
    BARNES, DM
    [J]. BRITISH MEDICAL JOURNAL, 1989, 299 (6707) : 1061 - 1062
  • [4] STOCHASTIC APPEARANCE OF MAMMARY-TUMORS IN TRANSGENIC MICE CARRYING THE MMTV/C-NEU ONCOGENE
    BOUCHARD, L
    LAMARRE, L
    TREMBLAY, PJ
    JOLICOEUR, P
    [J]. CELL, 1989, 57 (06) : 931 - 936
  • [5] NCL-CB11, A NEW MONOCLONAL-ANTIBODY RECOGNIZING THE INTERNAL DOMAIN OF THE C-ERBB-2 ONCOGENE PROTEIN EFFECTIVE FOR USE ON FORMALIN-FIXED, PARAFFIN-EMBEDDED TISSUE
    CORBETT, IP
    HENRY, JA
    ANGUS, B
    WATCHORN, CJ
    WILKINSON, L
    HENNESSY, C
    GULLICK, WJ
    TUZI, NL
    MAY, FEB
    WESTLEY, BR
    HORNE, CHW
    [J]. JOURNAL OF PATHOLOGY, 1990, 161 (01) : 15 - 25
  • [6] C-ERBB-2 ONCOGENE PRODUCT STAINING IN GASTRIC ADENOCARCINOMA - AN IMMUNOHISTOCHEMICAL STUDY
    FALCK, VG
    GULLICK, WJ
    [J]. JOURNAL OF PATHOLOGY, 1989, 159 (02) : 107 - 111
  • [7] IMMUNOHISTOCHEMICAL DISTRIBUTION OF C-ERBB-2 IN INFILTRATING AND INSITU BREAST-CANCER
    GUSTERSON, BA
    MACHIN, LG
    GULLICK, WJ
    GIBBS, NM
    POWLES, TJ
    PRICE, P
    MCKINNA, A
    HARRISON, S
    [J]. INTERNATIONAL JOURNAL OF CANCER, 1988, 42 (06) : 842 - 845
  • [8] HART WR, 1977, CANCER, V40, P2333, DOI 10.1002/1097-0142(197711)40:5<2333::AID-CNCR2820400549>3.0.CO
  • [9] 2-#
  • [10] HELWIG EB, 1963, CANCER, V16, P387, DOI 10.1002/1097-0142(196303)16:3<387::AID-CNCR2820160314>3.0.CO